Natural gas, composed primarily of methane, is a critical component of the global energy mix. Yet, its storage remains a formidable challenge due to methane’s gaseous state under ambient conditions. Conventionally, natural gas is compressed under high pressures or cooled to extremely low temperatures (~-162 °C) to transform it into liquid natural gas (LNG) for storage and transport. Both methods, while effective, consume substantial energy and necessitate expensive infrastructure. An alternative, less-explored approach involves encapsulating methane molecules within water-based cages known as hydrates — ice-like crystalline structures capable of trapping gases. However, the practicality of hydrate-based storage has been hampered by the slow kinetics of hydrate formation, often taking hours to days.

The NUS team’s innovation hinges on the incorporation of specific amino acids into the freezing process of water, producing what they term “amino-acid-modified ice.” Upon exposing this modified ice to methane gas, the resulting hydrate formation occurs within minutes, achieving 90% of theoretical storage capacity rapidly. This is a remarkable improvement compared to the sluggish hydrate formation timeline of conventional methods. The key lies in how amino acids alter the physical and chemical characteristics of the ice surface, thereby facilitating swift methane encapsulation.

At the molecular level, certain hydrophobic amino acids such as tryptophan, methionine, and leucine interact with the ice matrix to create microscopically thin liquid-like layers on the ice surface during methane injection. These layers serve as nucleation sites where hydrate crystallization initiates and accelerates, producing a porous, sponge-like hydrate structure that is both efficient and rapid in gas capture. This behavior contrasts with pure ice’s tendency to develop a dense, impermeable outer shell that obstructs further methane diffusion, significantly decelerating hydrate growth.

Advanced Raman spectroscopy investigations provided conclusive insight into the methane encapsulation mechanism. These studies revealed that methane molecules quickly occupy two distinct cage types within the hydrate lattice with occupancies exceeding 90%, underscoring the dual benefit of the amino acid treatment: not only enhanced formation speed but also efficient molecular packing within the hydrate cages. This spectral evidence substantiates the notion that amino acids serve more than a superficial role, actively influencing the bulk hydrate structure at a molecular scale.

The researchers’ choice and systematic testing of different amino acids revealed a “design rule” dictating functionality based on amino acid properties. Hydrophobic amino acids were effective in promoting rapid hydrate formation, while hydrophilic amino acids such as histidine and arginine failed to produce comparable effects. This clarity in structure-function relationship guides the future rational design of tailored amino-acid-based additives aimed at optimizing solidified natural gas systems.

The implications of this advancement extend beyond mere acceleration of gas capture. This amino acid-based strategy circumvents the environmental risks associated with synthetic surfactants commonly employed to catalyze hydrate formation, which often contribute to aquatic toxicity and persistent foam generation during methane release. The biodegradable and non-foaming nature of amino acid-modified ice offers an environmentally sustainable alternative that reduces operational hazards and costs in large-scale applications.

Reusability and cycle stability are crucial for viable energy storage technologies. Impressively, the NUS team demonstrated that stored methane could be released on demand through gentle heating, after which the amino acid-modified ice could be re-frozen and reused multiple times without loss of efficacy. This ability to cycle the storage medium parallels battery charge-discharge functionality, positioning amino acid-modified hydrates as strong contenders for flexible, closed-loop natural gas storage solutions.

In addition to natural gas, the technique holds exciting promise for renewable biomethane sources, which are increasingly vital in decarbonizing the energy sector. Biomethane production is frequently decentralized and small-scale, often making traditional liquefaction or pressurized storage economically unfeasible. The compact, efficient, and environmentally friendly amino acid approach offers a scalable pathway to harness these emerging renewable gases more effectively.

Looking forward, the team envisions scaling the process from laboratory proof-of-concept to industrial relevance. Efforts include designing reactors that enhance triple-phase gas-liquid-solid contact necessary for efficient hydrate synthesis, exploring hydrate stability improvements via amino acid-engineered composite materials, and broadening the approach to other industrially relevant gases such as carbon dioxide and hydrogen. These applications could catalyze advancements in carbon capture, storage, and clean hydrogen economy technologies.

This newly unveiled approach creatively fuses biology and materials science, leveraging nature’s building blocks — amino acids — to address critical limitations in gas storage technology. The simplicity of mixing water with select amino acids followed by methane exposure stands in sharp contrast to the complexity and costliness of traditional methods. As Professor Linga eloquently summarized, this biodegradable, rapid, and reusable hydrate formation technique not only makes natural gas safer and greener but also adaptive for future energy landscapes.

In sum, the amino-acid-modified ice technology ushers in a promising new era for solidified natural gas storage, characterized by unprecedented formation speed, environmental sustainability, and cycle robustness. As global energy demands evolve, innovations like this that blend scientific insight with practicality could pivotally improve how we capture, store, and utilize methane and beyond — representing a powerful stride toward sustainable energy futures.

Subject of Research: Not applicable

Article Title: Rapid conversion of amino acid modified-ice to methane hydrate for sustainable energy storage

News Publication Date: 30-Sep-2025

Web References: https://rdcu.be/eITrV

References: 10.1038/s41467-025-63699-2

Image Credits: College of Design and Engineering at NUS

Keywords

Energy; Sustainable energy; Environmental sciences; Materials science

The crux of the ASAC approach lies in the methodical anchoring of foreign single atoms to chosen facets of reducible support materials. This strategic anchoring allows these catalysts to sidestep the cumbersome oxidative addition step that is typically associated with cross-coupling reactions. In traditional scenarios, this oxidative addition is a significant hurdle, primarily due to the energy barriers that impede reaction kinetics. By effectively bypassing this step, the NUS team has opened up new possibilities for enhancing the efficiency and selectivity of catalytic reactions.

Single-atom catalysts (SACs) have emerged as a focal point of modern catalysis. The ability of SACs to optimize the utilization of every atom in a catalytic setting, whilst also providing uniquely defined and active reaction sites, has garnered significant attention in recent years. SACs present a unique synthesis of the advantages found in both conventional and modern catalytic systems. The key lies in maintaining the stability of the metal atom while simultaneously ensuring that it remains sufficiently reactive. However, achieving this balance proves difficult, as the strong interactions often necessary between metal atoms and their supports can restrict reactivity, particularly in complex multi-step reactions such as cross-coupling.

The NUS research team’s innovative anchoring-borrowing strategy represents a leap in catalyst design. In their study, they have successfully anchored palladium (Pd) single atoms onto cerium oxide (CeO2) surfaces. This arrangement is more than just a clever configuration; it allows the material to “borrow” oxygen atoms from its environment that serve as anchor points. The role of the metal oxide as an electron reservoir is equally pivotal, as it enhances the electron flow that stabilizes the Pd atoms, preventing over-oxidation and maintaining their catalytic activity. This structural adaptability enables the ASACs to respond to the dynamic requirements of the cross-coupling reactions without succumbing to the oxidative challenges typical in such processes.

Through rigorous experimental validation, the researchers demonstrated that their Pd1-CeO2(110) ASAC exhibits remarkable performance even when employed in challenging settings, such as reactions involving aryl chlorides and more complex substrates that have historically proven difficult to react. The data gleaned from their studies underscores the superiority of the ASACs over traditional catalysts in areas such as yield consistency, reaction stability, and overall turnover numbers. This advance could redefine the standards for what is achievable in large-scale pharmaceutical manufacturing while also ensuring efficient synthesis of high-value chemical products.

The implications of this research extend broadly. Beyond just high yields in cross-coupling reactions, ASACs exhibit robust versatility. They have shown efficacy across a plethora of reactions traditionally viewed as challenging, including the Heck and Sonogashira reactions, which involve significant challenges due to the intricacies of the substrate interactions. This versatility demonstrates the profound potential of ASACs to revolutionize various areas of catalysis and chemical synthesis.

Central to the ASAC’s functionality is the dynamic structural evolution of its palladium components. The design encourages the Pd atom to constantly adapt, optimizing its geometrical and electronic configurations to facilitate reactions more efficiently. This adaptability dramatically reduces the energy requirements, further enhancing catalytic activity. Advanced methodologies such as X-ray absorption near-edge structure (XANES) analysis were utilized to confirm the stability of the palladium’s oxidation state throughout the reaction, affirming that these catalysts maintain their activity over prolonged periods.

Associate Professor LU has articulated the broader significance of this research, emphasizing that the ASACs propose a more environmentally friendly approach to the age-old challenge of oxidative additions. By transcending the limitations that beleaguer both homogeneous and heterogeneous catalytic systems, this innovation heralds a new era in chemical synthesis, with promising implications for sustainability and efficiency in pharmaceutical production.

The future trajectory of this research appears equally promising. The research team is already considering ways to extend this catalytic approach to encompass a broader array of metals applicable to cross-coupling reactions. By modifying the combinations of single atoms used and partnering them with innovative support materials, there exists potential to enhance the catalytic performance of non-precious metals, making these processes not just more efficient, but also more accessible and sustainable in the long run.

With these advancements, the research not only charts a course for improvements in chemical reactions but also provides a compelling narrative for the future of heterogeneous catalysis. The findings represented in this study form a cornerstone for developing smarter, more efficient catalysts, driving a paradigm shift that could facilitate sustainable practices across various industrial sectors. The commitment to refining and extending this technology underlines the vital role that academic institutions play in addressing the critical challenges faced in chemical synthesis today, setting a high standard for future research efforts.

In conclusion, NUS’s artful single-atom catalysts symbolize a major milestone in the evolution of catalysis, where innovative designs pave the way for unprecedented chemical transformations. As this research further matures, it stands poised to significantly contribute to the broader field of chemical manufacturing, enabling enhanced reactions that could alter the landscape of how pharmaceuticals and fine chemicals are produced.

Subject of Research: Artful Single-Atom Catalysts
Article Title: Defying the oxidative-addition prerequisite in cross-coupling through artful single-atom catalysts
News Publication Date: 4-Apr-2025
Web References:
References:
Image Credits: Nature Communications

Keywords

Despite the rich structural diversity of four-membered heterocycles, such as oxetanes and β-lactones, their synthesis remains a challenging endeavor within organic chemistry. Not only are these compounds abundant in natural products, but they also play crucial roles in medicinal chemistry. Their unique features, particularly when fluorine is introduced into the molecular framework, often enhance the pharmacological effectiveness of the compounds they are part of. While the inclusion of fluorine can augment biological activity, achieving this has been a complex puzzle for the scientific community—until now.

The research team, led by Associate Professor Koh Ming Joo from NUS’s Department of Chemistry, alongside experts from the Department of Pharmacy and Pharmaceutical Sciences, embarked on this journey to engineer a solution. Their collaboration included contributions from Professor Eric Chan and Professor Liu Peng, who offered insights from their respective fields. Their collective expertise laid the groundwork for what would culminate in a notable research outcome published in the prestigious journal Nature Chemistry in February 2025.

Central to this discovery is the team’s novel strategy that enables the selective insertion of a difluorocarbene species into the structure of readily accessible three-membered epoxides. This approach departs from traditional methods that often lead chemists into a quagmire of unfavorable reactions such as defluorination and ring rupture. Utilizing an inexpensive copper catalyst, this new methodology addresses these challenges head-on by stabilizing the difluorocarbene generated from a commercially viable organofluorine precursor. Consequently, the catalytic reaction promotes site-selective cleavage and cyclization of the epoxide, resulting in the formation of α,α-difluoro-oxetanes.

A vivid demonstration of the practical utility of this transformation came when the researchers succeeded in synthesizing fluorine-containing analogues of compounds familiar to medicinal chemists. For instance, creating analogues of oxetane, β-lactone, and carbonyl pharmacophores seldom tackled previously holds promise for the pharmaceutical industry. This pioneering work represents not just a technical achievement, but a significant leap towards enhancing our medicinal toolkit, fostering better drug design, and potentially leading to breakthroughs in treating previously futile-to-address diseases.

Prof. Liu’s computational studies complemented the experimental work, providing a deeper understanding of the reactivity involved and unveiling new mechanisms that elucidate these novel chemical transformations. This multifaceted approach showcases the strength that interdisciplinary collaboration can bring to scientific inquiry. In tandem with investigations led by Prof. Chan focusing on lipophilicity and metabolic stability, this body of research substantiates the potential role of fluorinated oxetanes as critical scaffolds in the realm of drug discovery.

As these researchers venture further into this uncharted territory, they are undertaking crucial studies to assess the biological properties of these novel compounds. The ongoing work aims to extend this methodology beyond fluorinated oxetanes to other classes of heterocyclic compounds that show promise as drug-like entities. This trajectory suggests an expansive horizon where chemistry serves not just as a foundational discipline but as a transformative force in medicine.

The implications of this research are far-reaching. By addressing the limitations imposed by traditional synthetic routes, the development of this catalytic methodology offers a reliable and efficient pathway to synthesizing previously inaccessible compounds. This prospective ability to design and create new small-molecule therapeutics could lead to the innovation of medications tailored specifically for the treatment of various diseases, possibly charting pathways to solutions in areas where conventional remedies have stalled or become ineffectual.

In a statement reflecting the enthusiasm and relevance of their work, Assoc Prof Koh captured the essence of their research: “By inventing a reliable route to fluorine-containing oxetanes, we can now incorporate these motifs into the design of novel small-molecule therapeutics. This opens up exciting opportunities to develop new medicines that could potentially treat previously incurable diseases.” His statement encapsulates the optimism that surrounds this transformative research, highlighting its potential impact on the future of medicinal chemistry.

With ongoing studies reinforcing the utility of their findings, the researchers are poised to unlock even further innovations within the field of drug discovery. As excitement mounts within the scientific community, the legacy of this research could well inspire future generations of chemists to tackle the complex challenges inherent to drug synthesis and development.

This novel approach to manipulating chemical structures, grounded in practical applicability and theoretical insights, serves not just an academic function but stands on the threshold of real-world application. The possibilities it opens are not merely theoretical; they hold promise to reshape pharmacotherapeutic strategies and enhance health outcomes for patients facing challenging medical conditions.

As we witness the fruits of overhauling traditional methods of pharmaceutical synthesis, this research serves as a beacon of inspiration—a call to action for chemists worldwide to pursue innovative prospects with renewed vigor and imagination.

Subject of Research: Not applicable
Article Title: Catalytic difluorocarbene insertion enables access to fluorinated oxetane isosteres
News Publication Date: 20-Feb-2025
Web References: Journal Article
References: DOI: 10.1038/s41557-024-01730-7
Image Credits: Credit: National University of Singapore

Keywords

Medicinal chemistry; Drug discovery; Discovery research; Drug design; Scientific method; Catalysis; Pharmaceuticals